In high-risk outpatients with COVID-19, remdesivir reduced COVID-19-related hospitalization or all-cause death at 28 d
ANNALS OF INTERNAL MEDICINE（2022）
摘要
Gottlieb RL, Vaca CE, Paredes R, et al. N Engl J Med. 2022;386:305-15. 34937145.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要